chitosan has been researched along with Experimental Hepatoma in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.57) | 18.7374 |
| 1990's | 2 (7.14) | 18.2507 |
| 2000's | 7 (25.00) | 29.6817 |
| 2010's | 14 (50.00) | 24.3611 |
| 2020's | 4 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Hu, S; Huang, K; Li, J; Qi, H; Wang, F | 1 |
| Jiang, L; Jin, F; Liu, S; Wang, Y; Wang, Z; Wei, X; Xu, Y; Yang, L; Yin, X; Zhang, C; Zhang, M; Zhang, Y | 1 |
| Fan, Z; Hou, Z; Li, T; Li, Y; Luo, F; Wang, S; Yan, J; Yang, L; Yin, W; Zhang, Q; Zhong, L | 1 |
| Dwivedi, P; Khatik, R; Kiran, S; Liang, G; Qiu, B; Wang, Z; Yang, Q; Zhi, D | 1 |
| Arafa, K; El-Sherbiny, IM; Emara, M; Hefnawy, A; Khalil, IH | 1 |
| Chi, J; Han, B; Jiang, Z; Liu, W | 1 |
| Hwang, H; Jeong, HJ; Kim, HS; Kwon, J; Lim, ST; Oh, PS; Park, HS; Sohn, MH | 1 |
| Gao, X; Li, Y; Wang, W; Wang, X; Yuan, Z; Zhang, Y | 1 |
| Chen, H; Cheng, M; Gao, X; Han, J; He, B; Li, Y; Wang, Y; Xu, H; Zhang, Z | 1 |
| Tang, C; Yin, C; Zhang, S | 1 |
| Bei, YY; Chen, WL; Hu, XJ; Jin, Y; Liu, Y; Xia, P; You, BG; Yuan, ZQ; Zhang, CG; Zhang, L; Zhang, XN; Zhou, XF; Zhu, QL | 1 |
| Jiang, B; Liu, F; Song, M; Wan, J; Yang, C; Zhou, D; Zhu, R | 1 |
| Song, T; Sun, R | 1 |
| Li, J; Oupický, D; Ping, Q; Qiao, H; Su, Z; Sun, M; Xie, Y; Zhang, C | 1 |
| Futakuchi, M; Hirose, M; Kawabe, M; Shirai, T; Tamano, S | 1 |
| Wen, Z; Xu, Y; Xu, Z | 1 |
| He, F; Huang, C; Qi, J; Yao, P; Yu, C | 1 |
| Florczyk, SJ; Kievit, FM; Leung, M; Park, JO; Veiseh, O; Wu, J; Zhang, M | 1 |
| Cheng, M; Han, J; He, B; Hou, Y; Li, Q; Wang, W; Wu, J; Xu, H; Ye, T; Zha, B; Zhou, R | 1 |
| Chen, HX; Cheng, MR; Han, J; He, B; Li, Q; Wan, T; Wang, W; Xu, HZ; Yang, FX; Ye, T; Zha, BB | 1 |
| Baik, HW; Han, SM; Kim, JS; Kim, YB; Kwak, BK; Lee, BM; Lee, MJ; Lee, YC; Shim, HJ; Son, SH; Tokura, S | 1 |
| Ding, Q; Guo, Q; Ping, Q; Qu, G; Shen, Z; Sun, Y; Wu, X; Yao, Z; Yuan, S; Zhang, C; Zhou, H | 1 |
| Hino, T; Kawashima, Y; Shimabayashi, S | 1 |
| Kato, Y; Machida, Y; Onishi, H | 2 |
| Ito, K; Kyotani, S; Miyazaki, M; Nishioka, Y; Ogiso, T; Ohnishi, S; Okamura, M; Tanada, S; Tanaka, T; Yamamoto, Y | 1 |
| Ito, K; Kyotani, S; Miyazaki, M; Morita, M; Nishioka, Y; Ohnishi, S; Okamura, M; Okazaki, K; Sakamoto, Y; Yamamoto, Y | 1 |
| Fukudome, H; Tanaka, K | 1 |
1 review(s) available for chitosan and Experimental Hepatoma
| Article | Year |
|---|---|
Basic study for stabilization of w/o/w emulsion and its application to transcatheter arterial embolization therapy.
Topics: Animals; Chemoembolization, Therapeutic; Chitin; Chitosan; Drug Stability; Emulsions; Epirubicin; Hepatic Artery; Humans; Iodized Oil; Liver Neoplasms, Experimental; Rats | 2000 |
27 other study(ies) available for chitosan and Experimental Hepatoma
| Article | Year |
|---|---|
Preparation and synergistic chemo-photothermal therapy of redox-responsive carboxymethyl cellulose/chitosan complex nanoparticles.
Topics: Animals; Antimetabolites, Antineoplastic; Carbohydrate Conformation; Carboxymethylcellulose Sodium; Cell Proliferation; Cell Survival; Chitosan; Drug Liberation; Drug Screening Assays, Antitumor; Fluorouracil; Hep G2 Cells; Humans; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Particle Size; Photothermal Therapy | 2022 |
Improvement in phenotype homeostasis of macrophages by chitosan nanoparticles and subsequent impacts on liver injury and tumor treatment.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Chitosan; Homeostasis; Liver Neoplasms, Experimental; Macrophage Activation; Macrophages; Mice; Nanoparticles; Particle Size; Phenotype; RAW 264.7 Cells | 2022 |
pH-responsive stearic acid-O-carboxymethyl chitosan assemblies as carriers delivering small molecular drug for chemotherapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Female; Humans; Hydrogen-Ion Concentration; Liver Neoplasms, Experimental; Mice; Mice, Nude; Stearic Acids; Xenograft Model Antitumor Assays | 2019 |
Integrin α
Topics: Animals; Arsenates; Chitosan; Gadolinium; Hep G2 Cells; Humans; Integrin alphaVbeta3; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Nanostructures; Neoplasm Proteins; Oligopeptides | 2020 |
Dual-Ligand Functionalized Core-Shell Chitosan-Based Nanocarrier for Hepatocellular Carcinoma-Targeted Drug Delivery.
Topics: Animals; Carcinoma, Hepatocellular; Chitosan; Disaccharides; Doxorubicin; Drug Carriers; Drug Delivery Systems; Female; Glycyrrhetinic Acid; Hep G2 Cells; Humans; Liver Neoplasms, Experimental; Nanoparticles; Rats, Wistar | 2020 |
Preparation and pharmacological evaluation of norcantharidin-conjugated carboxymethyl chitosan in mice bearing hepatocellular carcinoma.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Chitosan; Drug Carriers; Liver Neoplasms, Experimental; Mice; Xenograft Model Antitumor Assays | 2017 |
Chitosan-Based Hydrogel Microparticles for Treatment of Carcinoma in a Rabbit VX2 Liver Tumor Model.
Topics: Angiography; Animals; Chitosan; Contrast Media; Disease Models, Animal; Embolization, Therapeutic; Hydrogels; Liver Function Tests; Liver Neoplasms, Experimental; Rabbits; Tomography, X-Ray Computed; Tumor Burden | 2018 |
Chitosan sulfate inhibits angiogenesis via blocking the VEGF/VEGFR2 pathway and suppresses tumor growth in vivo.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Chitosan; Dose-Response Relationship, Drug; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred Strains; Neovascularization, Pathologic; Protein Kinase Inhibitors; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factors | 2019 |
Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Proliferation; Chitosan; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Carriers; Female; Fluorouracil; Glycyrrhetinic Acid; Interferon-gamma; Interleukin-2; Killer Cells, Natural; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; Particle Size; Survival Rate; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Time Factors | 2013 |
Effects of poly(ethylene glycol) grafting density on the tumor targeting efficacy of nanoparticles with ligand modification.
Topics: Animals; Animals, Outbred Strains; Antineoplastic Agents, Phytogenic; Biological Transport; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Compounding; Drug Delivery Systems; Folic Acid; Humans; Ligands; Linoleic Acid; Liver; Liver Neoplasms, Experimental; Malates; Male; Mice; Nanoparticles; Paclitaxel; Particle Size; Polyethylene Glycols; Polymers; Random Allocation; Surface Properties; Tissue Distribution | 2015 |
Novel self-assembled micelles based on palmitoyl-trimethyl-chitosan for efficient delivery of harmine to liver cancer.
Topics: Animals; Antineoplastic Agents; Chitosan; Drug Delivery Systems; Female; Harmine; Hep G2 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Micelles; Monoamine Oxidase Inhibitors; Palmitic Acid; Particle Size | 2014 |
Biological effects of irradiating hepatocellular carcinoma cells by internal exposure with 125I-labeled 5-iodo-2'-deoxyuridine-chitosan drug loading nanoparticles.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Chitosan; DNA Damage; DNA Repair; Hep G2 Cells; Humans; Idoxuridine; Iodine Radioisotopes; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Nanoparticles; Rabbits; Radiopharmaceuticals | 2014 |
Pharmacodynamics study of zedoary turmeric oil chitosan microspheres administered via arterial embolization.
Topics: Animals; Chitosan; Delayed-Action Preparations; Embolization, Therapeutic; Liver Neoplasms, Experimental; Microspheres; Plant Extracts; Rats; Rats, Sprague-Dawley | 2016 |
Arginine-Modified Nanostructured Lipid Carriers with Charge-Reversal and pH-Sensitive Membranolytic Properties for Anticancer Drug Delivery.
Topics: Animals; Antineoplastic Agents; Arginine; Camptothecin; Chitosan; Drug Carriers; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Liver Neoplasms, Experimental; Male; Mice; Nanostructures; Rats; Rats, Sprague-Dawley; Xenograft Model Antitumor Assays | 2017 |
Modifying effects of chitin, chitosan and their related compounds on 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in a rat medium-term hepatocarcinogenesis model, and their post-initiation effects in a female rat 2-stage multi-organ carcinogenesi
Topics: Animals; Body Weight; Carcinogenicity Tests; Carcinogens; Chitin; Chitosan; Colonic Neoplasms; Diethylnitrosamine; Female; Glutathione Peroxidase; Liver Neoplasms, Experimental; Male; Mammary Neoplasms, Animal; Organ Size; Quinoxalines; Rats; Rats, Inbred F344 | 2008 |
Chitosan nanoparticles inhibit the growth of human hepatocellular carcinoma xenografts through an antiangiogenic mechanism.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Chelating Agents; Chitosan; Female; Humans; Immunoenzyme Techniques; Liver Neoplasms, Experimental; Mice; Mice, Nude; Nanoparticles; Necrosis; Neovascularization, Pathologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2009 |
Nanoparticles with dextran/chitosan shell and BSA/chitosan core--doxorubicin loading and delivery.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Dextrans; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Drug Compounding; Female; Fluorescence; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Light; Liver Neoplasms, Experimental; Maillard Reaction; Male; Mice; Microscopy, Atomic Force; Nanoparticles; Scattering, Radiation; Serum Albumin, Bovine; Solubility; Surface Properties; Technology, Pharmaceutical; Time Factors; Tumor Burden | 2010 |
Chitosan-alginate scaffold culture system for hepatocellular carcinoma increases malignancy and drug resistance.
Topics: Alginates; Animals; Antineoplastic Agents; Biocompatible Materials; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Doxorubicin; Drug Resistance, Neoplasm; Glucuronic Acid; Hexuronic Acids; Humans; Liver Neoplasms, Experimental; Male; Mice; Mice, Nude; Microscopy, Electron, Scanning; Neovascularization, Pathologic; Tissue Scaffolds; Xenograft Model Antitumor Assays | 2010 |
Synthesis of galactosylated chitosan/5-fluorouracil nanoparticles and its characteristics, in vitro and in vivo release studies.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Female; Fluorouracil; G1 Phase Cell Cycle Checkpoints; Humans; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; Resting Phase, Cell Cycle | 2012 |
Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Chitosan; Cytotoxicity, Immunologic; Delayed-Action Preparations; Drug Carriers; Female; Fluorouracil; Killer Cells, Natural; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; T-Lymphocytes, Cytotoxic; Time Factors; Tumor Burden | 2012 |
Preparation of doxorubicin-containing chitosan microspheres for transcatheter arterial chemoembolization of hepatocellular carcinoma.
Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry, Physical; Chemoembolization, Therapeutic; Chitosan; Delayed-Action Preparations; Doxorubicin; Freeze Drying; Liver Neoplasms, Experimental; Male; Microscopy, Electron, Scanning; Microspheres; Rabbits; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
Topics: Alkanesulfonic Acids; Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Biological Availability; Carcinoma, Ehrlich Tumor; Carcinoma, Lewis Lung; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Female; Hemolysis; Humans; Liver Neoplasms, Experimental; Male; Materials Testing; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Micelles; Paclitaxel; Rats; Rats, Sprague-Dawley; Safety; Sarcoma 180; Tissue Distribution | 2008 |
Lactosaminated and intact N-succinyl-chitosans as drug carriers in liver metastasis.
Topics: Animals; Area Under Curve; Chitin; Chitosan; Drug Carriers; Injections, Intravenous; Lactose; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Mitomycin; Neoplasm Metastasis; Tissue Distribution | 2001 |
Efficacy of lactosaminated and intact N-succinylchitosan-mitomycin C conjugates against M5076 liver metastatic cancer.
Topics: Amino Sugars; Animals; Area Under Curve; Chitin; Chitosan; Drug Administration Schedule; Fluorescein-5-isothiocyanate; Humans; Injections, Intravenous; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Mitomycin; Neoplasm Metastasis; Tissue Distribution; Treatment Outcome; Tumor Cells, Cultured | 2002 |
A study of embolizing materials for chemo-embolization therapy of hepatocellular carcinoma: antitumor effect of cis-diamminedichloroplatinum(II) albumin microspheres, containing chitin and treated with chitosan on rabbits with VX2 hepatic tumors.
Topics: Albumins; Animals; Chemoembolization, Therapeutic; Chitin; Chitosan; Cisplatin; Liver Neoplasms, Experimental; Male; Microspheres; Rabbits | 1992 |
A study of embolizing materials for chemo-embolization therapy of hepatocellular carcinoma: embolic effect of cisplatin albumin microspheres using chitin and chitosan in dogs, and changes of cisplatin content in blood and tissue.
Topics: Animals; Chemoembolization, Therapeutic; Chitin; Chitosan; Cisplatin; Dogs; Liver Neoplasms, Experimental; Microspheres | 1992 |
A method for observing intracellular structures of free cells by scanning electron microscopy.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Line; Cell Membrane; Chitin; Chitosan; Chlorocebus aethiops; Endoplasmic Reticulum; Golgi Apparatus; Kidney; Liver Neoplasms, Experimental; Mice; Microscopy, Electron, Scanning; Mitochondria; Organoids; Rats | 1986 |